ALDH1A1 and acute myeloid leukemia: These facts, taken together with our finding of the association of the high RNA expression levels of ALDH1A1 and ALDH2 in AML patients with a poor prognosis immediately suggest the development of a companion diagnostic that facilitates identifying the patients that are most likely to benefit from anti-ALDH and anti-PD1 treatments by measuring RNA expression.